Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
For broader treatment browsing, see our Diabetes Care category
52 In a phase 1b trial done to evaluate the safety, pharmacokinetics and pharmacodynamics of orforglipron in patients with T2DM, orforglipron resulted in significant reductions in HbA1c, fasting blood glucose and body weight, with an adverse event profile consistent with that of other GLP-1RA
A healthcare provider can offer personalized advice, taking into account these factors alongside the latest clinical research to recommend the most appropriate medication
Diet and exercise alone are not always enough to counteract the influence of genetics and age on our bodies
US$ 22.99
US$ 27.61
US$ 25.01
US$ 23.72
